Discover stories, ideas, and inspiration from this collection.
kelly research technologies
Hunter James Kelly Research Institute
Lawrence Wrabetz and Laura Feltri, two highly esteemed neuroscientists, have joined the University at Buffalo Hunter James Kelly Research Institute as researchers in partnership with Hunter’s Hope Foundation – established by Buffalo Bills Hall-of-Famer Jim Kelly after their infant son Hunter Kelly died of Krabbe leukodystrophy – one of several diseases which destroy myelin sheaths […]
Kelly Research Radionics
Kelly Research Technologies is a second generation family business dedicated to manufacturing and distributing high quality scalar and phase conjugate technology for use by radionic, psychotronic, and other subtle energy researchers and practitioners. Established in 1978 to honor Peter J. Kelly’s legacy – working alongside such luminaries of radionics as T. Galen Hieronymus, Tom Bearden, […]
Kelly Research Technologies
Kelly Research Technologies is a second generation family business dedicated to the manufacture and distribution of top quality scalar and phase conjugate technology for Radionic, Psychotronic, and other subtle energy researchers and practitioners worldwide. Peter Kelly founded both Interdimensional Sciences and Dimensional Sciences before leaving this work behind him with us today. Ed Kelly Kelly […]
Kelly Research – AI and Copyright Issues
Kelly Research brings more than two decades of equity research expertise in healthcare to Leerink Partners as Senior Managing Director, where he leads key strategic initiatives related to research product management and analyst development. Prior to Leerink, he served as Associate Director of Research with Credit Suisse. As any good introduction should, a successful introduction […]
Hunter James Kelly Research Institute
Investigators from Hunter James Kelly Research Institute have created a mathematical tool that could significantly improve newborn screening for Krabbe disease. Furthermore, this research could also assist in finding treatments for other neurodegenerative conditions like Parkinson’s and multiple sclerosis. Lawrence Wrabetz, head of the Myelin Biology Unit at San Raffaele Scientific Institute in Milan and […]